Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_assertion type Assertion NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_head.
- NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_assertion description "[Despite advances in hepatitis C treatment, substantial clinical hurdles remain to achieve universal cure and global control of infection.Saeed et al. identified SEC14L2 as a host factor permitting replication of clinical HCV isolates in cell culture, providing a novel system to model infection of patient-derived viruses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_provenance.
- NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_assertion evidence source_evidence_literature NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_provenance.
- NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_assertion SIO_000772 26441247 NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_provenance.
- NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_assertion wasDerivedFrom befree-2016 NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_provenance.
- NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_assertion wasGeneratedBy ECO_0000203 NP1294742.RAgqpPXG9Iu8lN413I-WUT17H_0T6cSo3ox6RsKTz7coA130_provenance.